维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Oflazoglu"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells 显示文摘	Ostberg JR Dayane BE Yuan M Oflazoglu E Repasky EA	2007	J Leukoc Biol2007，82，5：	1
2	Targeting CD30/ CD30L in oncology and autoimmune and inflammatory diseases显示文摘	Oflazoglu E Grewal IS Gerber H	2009	Adv Exp Med Biol2009，647，：	1
3	Evolution of anti-CD20 monoclonal antibody therapeutics in oncology显示文摘	Oflazoglu E Audoly L P	2010	MAbs2010，2，1：	1
4	Evolution of anti-CD20 monoclonal antibody therapeutics in oncology显示文摘	Oflazoglu E Audoly LP		0，，：	1
5	Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance显示文摘	Isak B Oflazoglu B Tanridag T	2008	Diabetes Metab Res Rev2008，24，7：	1
6	Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40显示文摘	Oflazoglu E Stone IJ Brown L	2009	Cancer2009，100，1：	1
7	Brainstem auditory evoked potentials and middle latency auditory evoked po- tentials in patients with impaired glucose tolerance显示文摘	Yitmen I Oflazoglu B Isak B	2008	Di- abet Med2008，25，7：	1
8	Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases 显示文摘	Oflazoglu E Grewal IS Gerber H	2009	Adv Exp Med Biol2009，647，：	1
9	Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lympho- ma显示文摘	Oflazoglu E Kissler KM Sievers EL	2008	Br J Haematol2008，142，1：	1
10	Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities 显示文摘	McZEarcherm JA Oflazoglu E Francisco L	2007	Blood2007，109，3：	1
11	Magnetic resonance imaging in amyotrophic lateral sclerosis 显示文摘	Basak M Erturk M Oflazoglu B	2002	Acta Neurol Scand2002，105，5：	1
12	Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with clsplatin 显示文摘	Sharad Ghamande Bonnie L Hylander Ezogelin Oflazoglu	2001	Cancer Research2001，61，：	1
13	Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis 显示文摘	Oflazoglu E Boursalian TE Zeng W	2009	J Immunol2009，183，6：	1
14	Engi- neered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitum or activities显示文摘	McZEarcherm JA Oflazoglu E Francisco L	2007	Blood2007，109，3：	1
15	Recombinant CD40 ligand therapy has significant antitumor effects on CD40 - positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin显示文摘	Ghammnde S Hylander BL Oflazoglu E	2001	Canc Res2001，61，20：	1
16	Enhancement of natural killer (NK) cell cytotoxieity by feverrange thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells 显示文摘	Ostberg JR Dayanc BE Yuan M Oflazoglu E Repasky EA	2007	J Leukoc Biol2007，82，5：	1
17	Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin显示文摘	Ghamande S Hylander BL Oflazoglu E	2001	Cancer Res2001，61，20：	1
18	Targeting CD30/CD30L in oncology and autoimmune and inflamm- atory diseases 显示文摘	OFLAZOGLU E GREWAL f S GERBER H	2009	Adv Exp Med Biol2009，647，：	1
19	Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker显示文摘	OFLAZOGLU E STONE I J GORDON K		0，，19：	1
20	Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities显示文摘	MCEARCHERN J A OFLAZOGLU E FRANCISCO L		0，，03：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示